Cellosaurus logo
expasy logo

Cellosaurus SFT-T1 (CVCL_C6JI)

[Text version]
Cell line name SFT-T1
Accession CVCL_C6JI
Resource Identification Initiative To cite this cell line use: SFT-T1 (RRID:CVCL_C6JI)
Comments Miscellaneous: STR profile from personal communication of Baier, Dina.
Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
Sequence variations
  • Gene fusion; HGNC; HGNC:7627; NAB2 + HGNC; HGNC:11368; STAT6; Name(s)=NAB2-STAT6; Note=NAB2 exon 4 fused to STAT6 exon 2 (PubMed=36428694).
Disease Pleural solitary fibrous tumor (NCIt: C4457)
Solitary fibrous tumour/hemangiopericytoma (ORDO: Orphanet_2126)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 50Y
Category Cancer cell line
STR profile Source(s): Direct_author_submission

Markers:
AmelogeninX,Y
CSF1PO12
D3S135816,18
D5S81813
D7S82011,12
D8S117913
D13S3179,11
D16S53911,14
D18S5112,16
D21S1128,31
FGA19,23
Penta D10,13
Penta E7,14
TH017,10
TPOX8
vWA17,18

Run an STR similarity search on this cell line
Publications

PubMed=36428694; DOI=10.3390/cancers14225602; PMCID=PMC9688590
Ghanim B., Baier D., Pirker C., Mullauer L., Sinn K., Lang G., Hoetzenecker K., Berger W.
Trabectedin is active against two novel, patient-derived solitary fibrous pleural tumor cell lines and synergizes with ponatinib.
Cancers (Basel) 14:5602.1-5602.16(2022)

Cross-references
Encyclopedic resources Wikidata; Q116050499
Entry history
Entry creation15-Dec-2022
Last entry update19-Dec-2024
Version number5